|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.350 USD | +0.86% |
|
+1.95% | +44.17% |
| 08/07 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 08/07 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
| Market Cap | 43Cr 38Cr 36Cr 33Cr 61Cr 4.17TCr 62Cr 423Cr 165.21Cr 2.06TCr 163.25Cr 159.73Cr 7.12TCr | P/E 2026 * |
-4.82x | P/E 2027 * | -4.37x |
|---|---|---|---|---|---|
| Enterprise Value | 43Cr 38Cr 36Cr 33Cr 61Cr 4.17TCr 62Cr 423Cr 165.21Cr 2.06TCr 163.25Cr 159.73Cr 7.12TCr | EV / Sales 2026 * |
4,045x | EV / Sales 2027 * | 2,609x |
| Free-Float |
92.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | +0.86% | ||
| 1 week | +1.95% | ||
| Current month | -12.64% | ||
| 1 month | -13.60% | ||
| 3 months | -12.64% | ||
| 6 months | +29.83% | ||
| Current year | +44.17% |
| 1 week | 2.29 |  | 2.52 |
| 1 month | 2.29 | | 2.84 |
| Current year | 1.36 | | 3.1 |
| 1 year | 0.48 | | 3.1 |
| 3 years | 0.24 | | 4.14 |
| 5 years | 0.24 | | 4.2 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 01/01/2026 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 06/07/2026 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 61 | 14/06/2017 |
Bart Friedman
BRD | Director/Board Member | 81 | 23/11/2015 |
| Director/Board Member | 77 | 03/03/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Other | Chief Financial Officer | 4,50,625 | 0.2414% | ||
| 06/07/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 15/06/26 | Free | Director | 1,30,000 | 0.0697% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.86% | +1.95% | +345.50% | -32.37% | 43Cr | |
| -1.82% | +5.03% | +56.71% | +66.69% | 5.73TCr | |
| -0.27% | +5.74% | +40.26% | +80.17% | 5.5TCr | |
| -2.05% | -2.14% | +2.93% | +413.38% | 2.32TCr | |
| +1.97% | -1.16% | -19.24% | -13.25% | 2.26TCr | |
| -1.13% | +4.54% | +22.73% | -8.06% | 2.05TCr | |
| +1.57% | +2.09% | +28.01% | -27.56% | 1.76TCr | |
| -0.10% | +5.57% | +38.63% | +565.16% | 1.57TCr | |
| +5.29% | 0.00% | +185.09% | +332.66% | 1.45TCr | |
| +0.79% | +0.50% | +25.73% | +184.74% | 1.39TCr | |
| Average | +0.59% | +1.00% | +72.63% | +156.16% | 2.41TCr | |
| Weighted average by Cap. | -0.06% | +1.92% | +40.92% | +137.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1L 94.5T 87.97T 80.79T 2L 1.03Cr 2L 10.46L 4L 50.9L 4L 4L 1.76Cr | 2L 1L 1L 1L 2L 1.6Cr 2L 16.21L 6L 78.92L 6L 6L 2.73Cr |
| Net income | -7.71Cr -6.78Cr -6.31Cr -5.8Cr -11Cr -739.59Cr -11Cr -75Cr -29Cr -365.2Cr -29Cr -28Cr -1.26TCr | -8.98Cr -7.9Cr -7.35Cr -6.75Cr -13Cr -861.56Cr -13Cr -87Cr -34Cr -425.42Cr -34Cr -33Cr -1.47TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $2.350 | +0.86% | 10,44,747 |
| 24/26/24 | $2.330 | -2.92% | 9,84,979 |
| 23/26/23 | $2.400 | +0.84% | 47,28,431 |
| 22/26/22 | $2.380 | -1.24% | 10,86,787 |
| 21/26/21 | $2.410 | +4.56% | 17,79,649 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
